Directors’ Dealings | 1 March 2023 12:09

aap Implantate AG: Merval AG, Granting of 545,704 subscription rights within a capital increase with subsription rights

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
01.03.2023 / 12:09 CET/CEST
The issuer is solely responsible for the content of this announcement.

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Name and legal form: Merval AG

2. Reason for the notification

a) Position / status

Person closely associated with:
Title:	Dr. med.
First name:	Nathalie
Last name(s):	Krebs
Position:	Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

aap Implantate AG

b) LEI

39120001TRQTQ01LPP57

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type:	Financial instrument linked to a share or a debt instrument
Description:	Subscription Right (ISIN: DE000A32VP81, WKN: A32 VP8)

b) Nature of the transaction

Granting of 545,704 subscription rights within a capital increase with subsription rights

c) Price(s) and volume(s)

Price(s)	Volume(s)
0.00 EUR	0.00 EUR

d) Aggregated information

Price	Aggregated volume
0.00 EUR	0.00 EUR

e) Date of the transaction

2023-02-28; UTC+1

f) Place of the transaction

Outside a trading venue

01.03.2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

Language:	English
Company:	aap Implantate AG
	Lorenzweg 5
	12099 Berlin
	Germany
Internet:	www.aap.de

End of News EQS News Service